MENU

INSP Stock Inspire Medical Systems (INSP, $93.05) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 20, 2025

A.I.dvisor
at Tickeron.com
Loading...
INSP - Inspire Medical Systems
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $93.05
Daily change: +$2.99 (+3.32%)
Daily volume: 928.1K
Industry: Medical/Nursing Services
This is a Bullish indicator signaling INSP's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 48 similar cases where INSP's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

INSP in +5.33% Uptrend, rising for three consecutive days on August 20, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INSP advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INSP's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 19, 2025. You may want to consider a long position or call options on INSP as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INSP just turned positive on August 20, 2025. Looking at past instances where INSP's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

INSP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INSP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INSP entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.997) is normal, around the industry mean (59.673). P/E Ratio (52.655) is within average values for comparable stocks, (38.600). INSP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.719). INSP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (3.246) is also within normal values, averaging (77.204).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INSP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INSP showed earnings on August 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of implantable neurostimulation systems to treat obstructive sleep apnea

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5500 Wayzata Boulevard
Phone
+1 844 672-4357
Employees
1011
Web
https://www.inspiresleep.com